Literature DB >> 2008278

A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage.

M G Speaker1, P N Guerriero, J A Met, C T Coad, A Berger, M Marmor.   

Abstract

The authors performed a case-control study of risk factors for suprachoroidal expulsive hemorrhage (SEH); the study involved 68 SEH cases at their institution from 1981 to 1986. The authors examined 113 variables in the study group and a procedure-matched control group of 217 patients randomly selected from the 35,459 patients who underwent intraocular surgery during this period, and subjected them to bivariate and conditional logistic regression analysis. The incidence of SEH was 0.19% overall, 0.16% for lens-related procedures, 0.15% for glaucoma surgery, 0.41% for retinal and vitreous procedures, and 0.56% for keratoplasty. Statistically significant risk factors for SEH in age-adjusted bivariate analyses included: glaucoma (P less than 0.0001), increased axial length (P less than 0.0001), elevated intraocular pressure (IOP) (P less than 0.0001), generalized atherosclerosis (P = 0.007), and elevated intraoperative pulse (P = 0.0001). Conditional logistic regression analysis with frequency matching on age identified significant independent risks associated with a history of glaucoma, elevated IOP, increased axial length, and intraoperative tachycardia. One of the models predicts a 752-fold increased theoretical relative risk of SEH for a patient with axial length greater than or equal to 25.8 mm, a history of glaucoma, preoperative IOP greater than 18 mmHg, and intraoperative pulse greater than or equal to 85 beats per minute. The visual outcome after SEH was best in cases of extracapsular cataract extraction (ECCE), compared with other procedures. Results suggest that attention to multiple preoperative and intraoperative ocular and systemic variables may allow identification and prophylaxis of patients at risk for SEH.

Entities:  

Mesh:

Year:  1991        PMID: 2008278     DOI: 10.1016/s0161-6420(91)32316-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  32 in total

Review 1.  Is it time for a new attitude to "simultaneous" bilateral cataract surgery?

Authors:  G T Smith; C S Liu
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

2.  Complicated posterior capsulorhexis: aetiology, management, and outcome.

Authors:  F Van Cauwenberge; J M Rakic; A Galand
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

Review 3.  Recent advances in customising cataract surgery.

Authors:  Malcolm Woodcock; Sunil Shah; Ronald J Smith
Journal:  BMJ       Date:  2004-01-10

4.  Safety and efficacy of manual small incision cataract surgery for phacolytic glaucoma.

Authors:  Geoffrey Tabin
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

Review 5.  [Complications after refractive lens exchange].

Authors:  D Kook; A Kampik; T Kohnen
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

6.  New equipment to prevent carbon dioxide rebreathing during eye surgery under retrobulbar anaesthesia.

Authors:  A Schlager; H Staud
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

7.  Rhegmatogenous retinal detachment associated with massive spontaneous suprachoroidal hemorrhage and prognosis of pars plana vitrectomy.

Authors:  Jie Zhang; Xiao-Hua Zhu; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

Review 8.  Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery.

Authors:  Kevin Kaplowitz; Joel S Schuman; Nils A Loewen
Journal:  Br J Ophthalmol       Date:  2013-12-12       Impact factor: 4.638

9.  Diode laser cyclophotocoagulation in Indian eyes: efficacy and safety.

Authors:  Kirti Singh; Divya Jain; Vikas Veerwal
Journal:  Int Ophthalmol       Date:  2016-04-09       Impact factor: 2.031

10.  [Massive subretinal hemorrhages. A challenge for vitreous body surgeons].

Authors:  J C Schmidt; C H Meyer; S Hörle
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.